Sejin Son

ORCID: 0000-0003-1523-2990
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA Interference and Gene Delivery
  • Immunotherapy and Immune Responses
  • Advanced biosensing and bioanalysis techniques
  • Nanoplatforms for cancer theranostics
  • Nanoparticle-Based Drug Delivery
  • Cancer Immunotherapy and Biomarkers
  • Virus-based gene therapy research
  • Ultrasound and Hyperthermia Applications
  • Photoacoustic and Ultrasonic Imaging
  • Electrospun Nanofibers in Biomedical Applications
  • Advanced Drug Delivery Systems
  • Nanopore and Nanochannel Transport Studies
  • Supramolecular Self-Assembly in Materials
  • Immune cells in cancer
  • Ferroptosis and cancer prognosis
  • Extracellular vesicles in disease
  • CAR-T cell therapy research
  • Ultrasound and Cavitation Phenomena
  • RNA modifications and cancer
  • Lipid Membrane Structure and Behavior
  • Hydrogels: synthesis, properties, applications
  • Supercapacitor Materials and Fabrication
  • Immune Cell Function and Interaction
  • Graphene and Nanomaterials Applications
  • Corneal Surgery and Treatments

Inha University
2022-2025

University of Michigan
2017-2023

BioSurfaces (United States)
2017-2023

Harvard University
2020

Brigham and Women's Hospital
2020

Korea Institute of Science and Technology
2012-2017

Pohang University of Science and Technology
2009-2014

Institute for Basic Science
2014

Ajou University
2008-2011

Photothermal therapy (PTT) is a promising cancer treatment modality, but PTT generally requires direct access to the source of light irradiation, thus precluding its utility against disseminated, metastatic tumors. Here, we demonstrate that combined with chemotherapy can trigger potent anti-tumor immunity disseminated Specifically, have developed polydopamine-coated spiky gold nanoparticles as new photothermal agent extensive stability and efficiency. Strikingly, single round sub-therapeutic...

10.1038/s41467-018-03473-9 article EN cc-by Nature Communications 2018-03-08

Although immune checkpoint blockade has shown initial success for various cancers, only a small subset of patients benefits from this therapy. Some chemotherapeutic drugs have been reported to induce antitumor T cell responses, prompting number clinical trials on combination chemoimmunotherapy. However, how achieve potent activation with traditional chemotherapeutics in manner that is safe, effective, and compatible immunotherapy remains unclear. We show high-density lipoprotein-mimicking...

10.1126/sciadv.aao1736 article EN cc-by-nc Science Advances 2018-04-06

Abstract The non-invasive photodynamic therapy has been limited to treat superficial tumours, primarily ascribed poor tissue penetration of light as the energy source. Herein, we designed a long-circulating hydrophilized titanium dioxide nanoparticle (HTiO 2 NP) that can be activated by ultrasound generate reactive oxygen species (ROS). When administered systemically mice, HTiO NPs effectively suppressed growth tumours after treatments. In tumour tissue, levels proinflammatory cytokines were...

10.1038/srep23200 article EN cc-by Scientific Reports 2016-03-21

Polymeric gene delivery vectors show great potential for the construction of ideal system. These systems harness their ability to incorporate versatile functional traits overcome most impediments encountered in delivery: from initial complexation target-specific release therapeutic nucleic acids at cytosol. Among numerous multifunctional polymers that have been designed and evaluated as vectors, with redox-sensitive (or bioreducible) domains gained attention terms structural traits. The...

10.1021/ar200248u article EN Accounts of Chemical Research 2011-11-30

Abstract Conventional chemotherapy is plagued with adverse side effects because cancer treatments are subject to numerous variations, most predominantly from drug resistance. Accordingly, multiple or multistage chemotherapeutic regimens often performed, combining two more drugs orthogonal and possibly synergistic mechanisms. In this respect, glycol chitosan (GC)-based nanoparticles (CNPs) serve as an effective platform vehicle that can encapsulate both chemotherapeutics siRNA achieve maximal...

10.1038/srep06878 article EN cc-by Scientific Reports 2014-11-03

Innate immune cells recognize and respond to pathogen-associated molecular patterns. In particular, polysaccharides found in the microbial cell wall are potent activators of dendritic (DCs). Here, we report a new class nanocapsules, termed sugar-capsules, entirely composed derived from wall. We show that sugar-capsules with flexible polysaccharide shell hollow core efficiently drain lymph nodes activate DCs. mannan (Mann-capsule) carrying mRNA (mRNA) promote strong DC activation,...

10.1021/acs.nanolett.9b03483 article EN Nano Letters 2020-02-05

Nanoparticles (NPs) can serve as a promising vaccine delivery platform for improving pharmacological property and codelivery of antigens adjuvants. However, NP-based vaccines are generally associated with complex synthesis postmodification procedures, which pose technical manufacturing challenges tailor-made production. Here, modularly programmed, polyethyleneimine (PEI)-based NP reported simple production personalized cancer vaccines. Briefly, PEI is conjugated neoantigens by facile...

10.1002/advs.202002577 article EN Advanced Science 2021-01-06

The present work illustrates unique design, construction and operation of an i-motif-based DNA nanomachine templated on gold nanoparticles (AuNPs), which utilizes pH-responsive dynamic motion i-motif strands aggregational behavior AuNPs to elicit programmed delivery therapeutic siRNA. pH-sensitive nucleic acids immobilized the consisted three functional segments, i.e., DNA, overhanging linker a At neutral pH, is hybridized with segment However, in endosomal acidic forms interstrand...

10.1021/nn5022567 article EN ACS Nano 2014-05-28

Theranostic nanoparticles hold great promise for simultaneous diagnosis of diseases, targeted drug delivery with minimal toxicity, and monitoring therapeutic efficacy.However, one the current challenges in developing theranostic is enhancing tumor-specific targeting both imaging probes anticancer agents.Herein, we report development tumor-homing echogenic glycol chitosan-based (Echo-CNPs) that concurrently execute cancer-targeted ultrasound (US) US-triggered delivery.To construct this novel...

10.7150/thno.13099 article EN cc-by Theranostics 2015-01-01

Gliomas are brain tumors with dismal prognoses. The standard-of-care treatments for gliomas include surgical resection, radiation, and temozolomide administration; however, they have been ineffective in providing significant increases median survival. Antigen-specific cancer vaccines immune checkpoint blockade may provide promising immunotherapeutic approaches gliomas.

10.1158/1078-0432.ccr-20-0341 article EN Clinical Cancer Research 2020-05-21

Transferrin (TF) is widely used as a tumor-targeting ligand for the delivery of anticancer drugs because TF receptor overexpressed on surface various fast-growing cancer cells. In this article, we report nanoparticles an siRNA carrier in vivo tumor-specific gene silencing. To produce carrying (NPs), both and were chemically modified with sulfhydryl groups that can build up self-cross-linked siRNA-TF NPs. Self-polymerized 5′-end thiol-modified (poly siRNA, psi) thiolated transferrin (tTF)...

10.1021/bc400226b article EN Bioconjugate Chemistry 2013-10-09
Coming Soon ...